rs41275794

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000602324.1(SPACA6-AS1):​n.301C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0251 in 445,190 control chromosomes in the GnomAD database, including 267 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.022 ( 72 hom., cov: 32)
Exomes 𝑓: 0.027 ( 195 hom. )

Consequence

SPACA6-AS1
ENST00000602324.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.00

Publications

19 publications found
Variant links:
Genes affected
SPACA6-AS1 (HGNC:49383): (SPACA6 antisense RNA 1)
SPACA6 (HGNC:27113): (sperm acrosome associated 6) Predicted to be involved in fusion of sperm to egg plasma membrane involved in single fertilization. Predicted to be located in acrosomal vesicle. [provided by Alliance of Genome Resources, Apr 2022]
MIR125A (HGNC:31505): (microRNA 125a) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0915 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPACA6NM_001316972.2 linkc.-371G>A upstream_gene_variant ENST00000637797.2 NP_001303901.1 W5XKT8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPACA6ENST00000637797.2 linkc.-371G>A upstream_gene_variant 1 NM_001316972.2 ENSP00000490829.1 W5XKT8-1

Frequencies

GnomAD3 genomes
AF:
0.0223
AC:
3381
AN:
151902
Hom.:
71
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00561
Gnomad AMI
AF:
0.0219
Gnomad AMR
AF:
0.0120
Gnomad ASJ
AF:
0.0135
Gnomad EAS
AF:
0.0990
Gnomad SAS
AF:
0.00787
Gnomad FIN
AF:
0.0348
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0287
Gnomad OTH
AF:
0.0129
GnomAD4 exome
AF:
0.0265
AC:
7777
AN:
293170
Hom.:
195
Cov.:
0
AF XY:
0.0249
AC XY:
3919
AN XY:
157076
show subpopulations
African (AFR)
AF:
0.00432
AC:
35
AN:
8110
American (AMR)
AF:
0.00577
AC:
97
AN:
16806
Ashkenazi Jewish (ASJ)
AF:
0.0124
AC:
100
AN:
8084
East Asian (EAS)
AF:
0.103
AC:
1458
AN:
14134
South Asian (SAS)
AF:
0.00954
AC:
428
AN:
44866
European-Finnish (FIN)
AF:
0.0315
AC:
934
AN:
29624
Middle Eastern (MID)
AF:
0.00401
AC:
11
AN:
2742
European-Non Finnish (NFE)
AF:
0.0285
AC:
4378
AN:
153874
Other (OTH)
AF:
0.0225
AC:
336
AN:
14930
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
356
712
1068
1424
1780
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0223
AC:
3389
AN:
152020
Hom.:
72
Cov.:
32
AF XY:
0.0226
AC XY:
1677
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.00560
AC:
232
AN:
41444
American (AMR)
AF:
0.0120
AC:
183
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.0135
AC:
47
AN:
3472
East Asian (EAS)
AF:
0.0986
AC:
509
AN:
5162
South Asian (SAS)
AF:
0.00808
AC:
39
AN:
4824
European-Finnish (FIN)
AF:
0.0348
AC:
368
AN:
10572
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0287
AC:
1954
AN:
67968
Other (OTH)
AF:
0.0171
AC:
36
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
166
332
498
664
830
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0154
Hom.:
5
Bravo
AF:
0.0200
Asia WGS
AF:
0.0510
AC:
177
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.7
DANN
Benign
0.69
PhyloP100
-1.0
PromoterAI
-0.021
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41275794; hg19: chr19-52196409; API